Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
GDRX
GDRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GDRX News
GoodRx Launches Monthly Subscription Plan for Affordable Medications
3d ago
seekingalpha
GoodRx Launches $14.99 Membership to Lower Healthcare Costs
3d ago
Newsfilter
Trump Administration Expands TrumpRx with Generic Medications
May 18 2026
CNBC
Investment Insights: Analysis of Chevron and Vertiv Prospects
May 13 2026
CNBC
GoodRx and Hims & Hers Financial Report Analysis
May 10 2026
Fool
Hims & Hers Health Continues to Outperform GoodRx in Revenue Growth
May 10 2026
NASDAQ.COM
GoodRx vs Hims & Hers: Revenue Stagnation vs Growth
May 10 2026
Yahoo Finance
GoodRx Q1 2026 Earnings Call Highlights
May 08 2026
seekingalpha
GoodRx Q1 Earnings Beat Expectations Amid Revenue Decline
May 06 2026
seekingalpha
GoodRx Launches Oral Ozempic® Treatment for Diabetes
May 01 2026
Newsfilter
GOODRX HOLDINGS INC - INCREASES AVAILABILITY OF OZEMPIC PILL STARTING AT $149 PER MONTH
May 01 2026
moomoo
GoodRx Launches FDA-Approved Foundayo Medication for Weight Management
Apr 09 2026
Newsfilter
GoodRx Stock Jumps 5.1% in Premarket Trading Following Announcement of Self-Pay Access to Eli Lilly's New Weight-Loss Medication
Apr 09 2026
moomoo
GOODRX INCREASES AVAILABILITY OF ELI LILLY'S NEW ORAL GLP-1, FOUNDAYO™, AND ZEPBOUND® KWIKPEN® WITH SELF-PAY PRICING AT OVER 70,000 PHARMACIES ACROSS THE COUNTRY
Apr 09 2026
moomoo
GoodRx Partners with Viatris to Offer Up to 85% Discounts on Medications
Mar 11 2026
seekingalpha
GOODRX TEAMS UP WITH VIATRIS TO PROVIDE UP TO 85% DISCOUNTS ON WELL-KNOWN BRAND MEDICATIONS
Mar 11 2026
moomoo
Show More News
